40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
40.22%
Revenue growth exceeding 1.5x VET's 15.53%. David Dodd would verify if faster growth reflects superior business model.
10.84%
Cost growth 1.1-1.25x VET's 8.97%. Bill Ackman would demand evidence of cost control initiatives.
145.91%
Gross profit growth exceeding 1.5x VET's 17.63%. David Dodd would verify competitive advantages.
75.38%
Margin expansion exceeding 1.5x VET's 1.82%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
7.37%
G&A growth while VET reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
-4.12%
Other expenses reduction while VET shows 100.00% growth. Joel Greenblatt would examine efficiency.
-2.24%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
4.25%
Total costs growth while VET reduces costs. John Neff would investigate differences.
-3.70%
Interest expense reduction while VET shows 9.53% growth. Joel Greenblatt would examine advantage.
-4.24%
D&A reduction while VET shows 0.56% growth. Joel Greenblatt would examine efficiency.
111.24%
EBITDA growth exceeding 1.5x VET's 24.70%. David Dodd would verify competitive advantages.
285.95%
EBITDA margin growth exceeding 1.5x VET's 7.93%. David Dodd would verify competitive advantages.
94.03%
Operating income growth exceeding 1.5x VET's 47.07%. David Dodd would verify competitive advantages.
95.74%
Operating margin growth exceeding 1.5x VET's 27.30%. David Dodd would verify competitive advantages.
-612.07%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
42.50%
Pre-tax income growth exceeding 1.5x VET's 18.24%. David Dodd would verify competitive advantages.
58.99%
Pre-tax margin growth exceeding 1.5x VET's 2.34%. David Dodd would verify competitive advantages.
65.59%
Tax expense growth 1.1-1.25x VET's 54.87%. Bill Ackman would demand explanation.
16.06%
Net income growth while VET declines. John Neff would investigate advantages.
40.14%
Net margin growth while VET declines. John Neff would investigate advantages.
16.00%
EPS growth while VET declines. John Neff would investigate advantages.
16.00%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
-0.03%
Share count reduction while VET shows 0.60% change. Joel Greenblatt would examine strategy.
No Data
No Data available this quarter, please select a different quarter.
